SCHEMBL13320587

SCHEMBL13320587

N#Cc1ncn([C@@H]2O[C@H](CO)C(O)[C@@H]2O)n1

nearest known ligand 0.59

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
LMNA P02545 4/20 0.59
ALDH1A1 P00352 4/20 0.59
SMN1; SMN2 Q16637 3/20 0.59
PNP P00491 2/20 0.59
ADORA1 P30542 2/20 0.59
THPO P40225 2/20 0.59
PMP22 Q01453 2/20 0.59
GLA P06280 1/20 0.59
EIF4E P06730 1/20 0.59
CYP3A4 P08684 1/20 0.59
TOP1 P11387 1/20 0.59
TSHR P16473 1/20 0.59
ADORA3 P0DMS8 1/20 0.50
CDK5 Q00535 1/20 0.45
CDK5R1 Q15078 1/20 0.45
HTT P42858 2/20 0.43
BLM P54132 2/20 0.43
GMNN O75496 1/20 0.43
TP53 P04637 1/20 0.43
NFKB1 P19838 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9780439 1.00 LMNA (0.59) LMNAALDH1A1SMN1; SMN2PNPADORA1
SCHEMBL13352081 1.00 LMNA (0.59) LMNAALDH1A1SMN1; SMN2PNPADORA1
SCHEMBL12150458 0.88 LMNA (0.45) LMNAALDH1A1SMN1; SMN2PNPADORA1
SCHEMBL2841617 0.86 LMNA (0.59) LMNAALDH1A1SMN1; SMN2PNPADORA1
SCHEMBL13320653 0.86 LMNA (0.59) LMNAALDH1A1SMN1; SMN2PNPADORA1
SCHEMBL13351996 0.86 LMNA (0.59) LMNAALDH1A1SMN1; SMN2PNPADORA1
SCHEMBL13320568 0.86 LMNA (0.59) LMNAALDH1A1SMN1; SMN2PNPADORA1
SCHEMBL12151512 0.85 ADORA3 (0.44) LMNAALDH1A1SMN1; SMN2PNPADORA1
SCHEMBL13320530 0.84 LMNA (0.56) LMNAALDH1A1SMN1; SMN2PNPADORA1
SCHEMBL14160485 0.84 LMNA (0.56) LMNAALDH1A1SMN1; SMN2PNPADORA1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20100129317-A1 AZOLE NUCLEOSIDES AND USE AS INHIBITORS OF RNA AND DNA VIRAL POLYMERASES SOUTHERN RESEARCH INSTITUTE (US) 2010-05-27 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100129317-A1 AZOLE NUCLEOSIDES AND USE AS INHIBITORS OF RNA AND DNA VIRAL POLYMERASES RNASEH1, RNASEL, POLR2E LMNA 739/4885ALDH1A1 2684/4885SMN1; SMN2 3616/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.